BrainCells' Series B Round

BrainCells raised a round of funding on April 21, 2008.

BrainCells is a biopharmaceutical company focused on the development of small molecule therapeutics for diseases of the central nervous system (CNS). The company's technology platform is based on rese…

Articles about BrainCells' Series B Round: